Mark Christianson, Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 38,293 shares at $1.46 ($55K) on 2023-12-27, disclosed to the SEC on 2023-12-27.
Open-market sale of $55k NMTC by Business Development Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.35 | 6,848 | $9K | 16.8% |
| 2 | $1.46 | 31,445 | $46K | 83.2% |
| Total | $1.44 avg | 38,293 | $55K | 100% |
| Filing → |
| NMTC | SELL | 2026-03-16 | $734 | — | Filing → |
| NMTC | SELL | 2026-03-12 | $11K | — | Filing → |
| NMTC | SELL | 2025-09-09 | $22K | — | Filing → |